Breast Neoplasm: Clinical Trials

4 trials for Breast Neoplasm, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 terminated, 1 completed, 1 withdrawn. 4 Phase 4.

By phase and status

PhaseTrialsStatus
Phase 44Terminated 2, Completed 1, Withdrawn 1

Follow Breast Neoplasm: new trials by email Literature Review of Breast Neoplasm trials Research Report on Breast Neoplasm

Trials (filtered) newest first · largest first

All 4 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Impact of eHealth-support on Quality of Life in Metastatic Breast Cancer Patients Treated With Palbociclib and Endocrine Therapy
Palbociclib, Fulvestrant, Anastrozole - Breast Neoplasm
Phase 4TerminatedPalleos Healthcare GmbH5322017-07-242022-01-06
Comparison of FlexHD and Alloderm Outcomes in Breast Reconstructive Surgery
FlexHD, Alloderm - Breast Neoplasm
Phase 4WithdrawnUniversity of Arkansas2016-03-012018-07-18
Will Preoperative MRI Breast in Women Under 56 Years With Breast Cancer Change Primary Treatment
MRI - Breast Neoplasm
Phase 4CompletedKarolinska University Hospital4402008-02-012013-05-29
Safety Study of CAELYX in Patients With Metastatic Breast Cancer Previously Treated With Anthracyclines (Study P04057)(TERMINATED)
Pegylated Liposomal Doxorubicin - Breast Neoplasm
Phase 4TerminatedMerck Sharp & Dohme LLC12006-02-012015-07-14

Narrower conditions

Breast Neoplasms (4)  ·  Neoplasm Metastasis (1)

Broader conditions

Breast Diseases (4)  ·  Neoplasms (4)  ·  Neoplasms by Site (4)  ·  Skin Diseases (4)  ·  Skin and Connective Tissue Diseases (4)  ·  Neoplastic Processes (1)  ·  Pathologic Processes (1)  ·  Pathological Conditions, Signs and Symptoms (1)

Interventions

Alloderm (1)  ·  Anastrozole (1)  ·  FlexHD (1)  ·  Fulvestrant (1)  ·  Letrozole (1)  ·  exemestane (1)  ·  liposomal doxorubicin (1)  ·  palbociclib (1)

Sponsors

Karolinska University Hospital (1)  ·  Merck Sharp & Dohme LLC (1)  ·  Palleos Healthcare GmbH (1)  ·  University of Arkansas (1)

Countries

Germany (1)  ·  Sweden (1)  ·  United States (1)

Top investigators

Brita Arver, MD PhD (1)  ·  Iris Reiser, PhD (1)  ·  Pallavi A Kumbla, MD (1)

Results publications

PMID 34611701, PMID 37201751